|
H10: as the lot number for the device was provided, a review of the device history records will be performed.The sample was not returned to the manufacturer for inspection/evaluation.Therefore, the investigation of the reported event is inconclusive.Based upon the available information, the definitive root cause for this event is unknown.The instructions for use (ifu) is adequate for the reported device/patient code(s) and provides general instructions for use, as well as warnings, precautions and potential complications associated with the device.Upon receipt of new or additional information, a follow-up report will be submitted as applicable.H10: d4 (expiration date: 11/2023).H11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
|
|
It was reported through the results of a clinical trial that after index procedure using a drug-coated balloon catheter in cephalic vein, the subject developed an adverse event of extravasation at puncture site.It was further reported that the adverse event did not result in additional reintervention.Reportedly, the severity of adverse event was mild, and the outcome was recovered.There was no reported patient injury.
|